Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease

As a result of increased prevalence of obesity worldwide, non-alcoholic fatty liver disease (NAFLD) has become one of the most common causes of chronic liver disease. Although most NAFLD cases remain benign, some progress to end-stage liver diseases such as cirrhosis and hepatocellular carcinoma. Th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Chronic Dis Transl Med
Autors principals: Jiang, Yong, Han, Tao, Zhang, Zhi-Guang, Li, Man, Qi, Feng-Xiang, Zhang, Ying, Ji, Ying-Lan
Format: Artigo
Idioma:Inglês
Publicat: KeAi Publishing 2017
Matèries:
Perspective
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643779/
https://ncbi.nlm.nih.gov/pubmed/29063072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cdtm.2017.06.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars